The lysosomal Ragulator complex plays an essential role in leukocyte trafficking by activating myosin II.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
07 06 2021
Historique:
received: 30 01 2020
accepted: 27 04 2021
entrez: 8 6 2021
pubmed: 9 6 2021
medline: 23 6 2021
Statut: epublish

Résumé

Lysosomes are involved in nutrient sensing via the mechanistic target of rapamycin complex 1 (mTORC1). mTORC1 is tethered to lysosomes by the Ragulator complex, a heteropentamer in which Lamtor1 wraps around Lamtor2-5. Although the Ragulator complex is required for cell migration, the mechanisms by which it participates in cell motility remain unknown. Here, we show that lysosomes move to the uropod in motile cells, providing the platform where Lamtor1 interacts with the myosin phosphatase Rho-interacting protein (MPRIP) independently of mTORC1 and interferes with the interaction between MPRIP and MYPT1, a subunit of myosin light chain phosphatase (MLCP), thereby increasing myosin II-mediated actomyosin contraction. Additionally, formation of the complete Ragulator complex is required for leukocyte migration and pathophysiological immune responses. Together, our findings demonstrate that the lysosomal Ragulator complex plays an essential role in leukocyte migration by activating myosin II through interacting with MPRIP.

Identifiants

pubmed: 34099704
doi: 10.1038/s41467-021-23654-3
pii: 10.1038/s41467-021-23654-3
pmc: PMC8184920
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Intracellular Signaling Peptides and Proteins 0
LAMTOR1 protein, human 0
MPRIP protein, human 0
Actomyosin 9013-26-7
Mechanistic Target of Rapamycin Complex 1 EC 2.7.11.1
Myosin-Light-Chain Phosphatase EC 3.1.3.53
PPP1R12A protein, human EC 3.1.3.53
Myosin Type II EC 3.6.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3333

Références

Nat Immunol. 2008 May;9(5):513-21
pubmed: 18391955
Nature. 2007 Apr 5;446(7136):680-4
pubmed: 17377534
Annu Rev Cell Dev Biol. 2016 Oct 6;32:469-490
pubmed: 27501447
Nat Rev Mol Cell Biol. 2009 Nov;10(11):778-90
pubmed: 19851336
Blood. 2013 Jan 10;121(2):298-307
pubmed: 23212520
Nat Rev Mol Cell Biol. 2013 May;14(5):283-96
pubmed: 23609508
J Immunol. 2018 Jun 1;200(11):3790-3800
pubmed: 29686050
Annu Rev Immunol. 2012;30:1-22
pubmed: 22136168
Nat Cell Biol. 2008 Aug;10(8):935-45
pubmed: 18604198
J Cell Biol. 2011 Sep 19;194(6):815-24
pubmed: 21930774
Science. 2003 Feb 28;299(5611):1400-3
pubmed: 12610307
Angew Chem Int Ed Engl. 2014 Jun 10;53(24):6085-9
pubmed: 24801356
Science. 1996 Jul 12;273(5272):245-8
pubmed: 8662509
Nat Rev Mol Cell Biol. 2019 Dec;20(12):738-752
pubmed: 31582855
J Cell Biol. 2017 Dec 4;216(12):4199-4215
pubmed: 28993467
Curr Opin Cell Biol. 2016 Apr;39:69-76
pubmed: 26921697
Ann Rheum Dis. 2018 Oct;77(10):1507-1515
pubmed: 29945921
Nature. 2008 May 1;453(7191):51-5
pubmed: 18451854
Nat Cell Biol. 2019 Feb;21(2):133-142
pubmed: 30602725
Blood. 2014 Jan 9;123(2):217-27
pubmed: 24092934
J Exp Med. 1992 Dec 1;176(6):1693-702
pubmed: 1460426
J Cell Sci. 2016 Dec 1;129(23):4329-4339
pubmed: 27799357
J Exp Med. 1987 Dec 1;166(6):1654-67
pubmed: 3119761
Nat Commun. 2016 Oct 12;7:13130
pubmed: 27731330
Nat Rev Immunol. 2002 Mar;2(3):151-61
pubmed: 11913066
Nat Commun. 2017 Nov 20;8(1):1625
pubmed: 29158492
J Biol Chem. 2005 Feb 11;280(6):4983-91
pubmed: 15545284
EMBO J. 2009 Mar 4;28(5):477-89
pubmed: 19177150
Nat Med. 2007 Jan;13(1):38-45
pubmed: 17195838
J Cell Biol. 2006 Dec 18;175(6):861-8
pubmed: 17178906
Science. 2017 Oct 20;358(6361):377-381
pubmed: 28935770
Nat Immunol. 2010 Jun;11(6):495-502
pubmed: 20473299
Cell. 2010 Apr 16;141(2):290-303
pubmed: 20381137
Am J Physiol Cell Physiol. 2005 Jul;289(1):C68-81
pubmed: 15728707
Immunol Today. 1998 Jan;19(1):37-44
pubmed: 9465487
Nat Rev Immunol. 2007 Sep;7(9):678-89
pubmed: 17717539
Sci Immunol. 2017 Oct 27;2(16):
pubmed: 29079589
J Biol Chem. 2013 Jun 21;288(25):18228-42
pubmed: 23653355
Nat Rev Immunol. 2017 Jan;17(1):30-48
pubmed: 27890914
Nat Immunol. 2010 Jul;11(7):594-600
pubmed: 20512151
J Biol Chem. 2005 Dec 30;280(52):42543-51
pubmed: 16257966
Immunity. 2008 Sep 19;29(3):325-42
pubmed: 18799141
EMBO J. 2007 Jan 24;26(2):505-15
pubmed: 17245434
J Cell Sci. 2013 Aug 15;126(Pt 16):3575-84
pubmed: 23781028
J Biol Chem. 2003 Dec 19;278(51):51484-93
pubmed: 14506264
J Cell Biol. 2014 May 26;205(4):525-40
pubmed: 24841562

Auteurs

Takeshi Nakatani (T)

Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Department of Immunopathology, WPI, Immunology Frontier Research Center (iFReC), Osaka University, Suita, Osaka, Japan.
Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan.

Kohei Tsujimoto (K)

Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Department of Immunopathology, WPI, Immunology Frontier Research Center (iFReC), Osaka University, Suita, Osaka, Japan.
Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan.
The Japan Science and Technology - Core Research for Evolutional Science and Technology (JST-CREST), Osaka University, Suita, Osaka, Japan.

JeongHoon Park (J)

The Japan Science and Technology - Core Research for Evolutional Science and Technology (JST-CREST), Osaka University, Suita, Osaka, Japan.
Department of Internal Medicine, Osaka Police Hospital, Ten-nouji-Ku, Osaka, Japan.

Tatsunori Jo (T)

Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Department of Immunopathology, WPI, Immunology Frontier Research Center (iFReC), Osaka University, Suita, Osaka, Japan.
Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan.

Tetsuya Kimura (T)

Department of Oncogene Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.

Yoshitomo Hayama (Y)

Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Department of Respiratory Medicine, Kinki Central Hospital, Itami, Hyogo, Japan.

Hachiro Konaka (H)

Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Department of Immunopathology, WPI, Immunology Frontier Research Center (iFReC), Osaka University, Suita, Osaka, Japan.
Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan.
The Japan Science and Technology - Core Research for Evolutional Science and Technology (JST-CREST), Osaka University, Suita, Osaka, Japan.

Takayoshi Morita (T)

Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Department of Immunopathology, WPI, Immunology Frontier Research Center (iFReC), Osaka University, Suita, Osaka, Japan.
Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan.

Yasuhiro Kato (Y)

Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Department of Immunopathology, WPI, Immunology Frontier Research Center (iFReC), Osaka University, Suita, Osaka, Japan.
Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan.

Masayuki Nishide (M)

Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Department of Immunopathology, WPI, Immunology Frontier Research Center (iFReC), Osaka University, Suita, Osaka, Japan.
Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan.

Shyohei Koyama (S)

Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Department of Immunopathology, WPI, Immunology Frontier Research Center (iFReC), Osaka University, Suita, Osaka, Japan.
Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan.
The Japan Science and Technology - Core Research for Evolutional Science and Technology (JST-CREST), Osaka University, Suita, Osaka, Japan.

Shigeyuki Nada (S)

Department of Oncogene Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.

Masato Okada (M)

Department of Oncogene Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.

Hyota Takamatsu (H)

Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan. thyota@imed3.med.osaka-u.ac.jp.
Department of Immunopathology, WPI, Immunology Frontier Research Center (iFReC), Osaka University, Suita, Osaka, Japan. thyota@imed3.med.osaka-u.ac.jp.
Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan. thyota@imed3.med.osaka-u.ac.jp.
The Japan Science and Technology - Core Research for Evolutional Science and Technology (JST-CREST), Osaka University, Suita, Osaka, Japan. thyota@imed3.med.osaka-u.ac.jp.

Atsushi Kumanogoh (A)

Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan. kumanogo@imed3.med.osaka-u.ac.jp.
Department of Immunopathology, WPI, Immunology Frontier Research Center (iFReC), Osaka University, Suita, Osaka, Japan. kumanogo@imed3.med.osaka-u.ac.jp.
Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan. kumanogo@imed3.med.osaka-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH